Risk of New‐Onset Ischaemic and Haemorrhagic Stroke in Patients With Type 2 Diabetes With Chronic Kidney Disease on SGLT‐2 Inhibitor Users: A Population‐Based Cohort Study. This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.